Argen X NV

(ARGNF)

By |

Profile

argenx SE is a clinical stage biotechnology company. It is engaged in the business of developing a pipeline of differentiated antibody-based therapies for the treatment of severe autoimmune diseases and cancer. Its product pipeline includes product candidates such as ARGX-113, ARGX-110, ARGX-115, ARGX-112 etc. The company operates in the Netherlands, Germany, Denmark, Belgium, Switzerland, the United States, and Luxembourg. It derives the majority of its revenues from Luxembourg.

Contact Information

Website: www.argenx.com
Email: info@argenx.com
Main Phone: +31 107038441
Address: Willemstraat 5
City / Town: Breda
Country: NLD
Postal Code: 4811 AH

Issuer Information

Exchange: GREY
CEO: Tim Van Hauwermeiren
Employees: 105


Gathering Data... Please wait

Profile

argenx SE is a clinical stage biotechnology company. It is engaged in the business of developing a pipeline of differentiated antibody-based therapies for the treatment of severe autoimmune diseases and cancer. Its product pipeline includes product candidates such as ARGX-113, ARGX-110, ARGX-115, ARGX-112 etc. The company operates in the Netherlands, Germany, Denmark, Belgium, Switzerland, the United States, and Luxembourg. It derives the majority of its revenues from Luxembourg.

Contact Information

Website: www.argenx.com
Email: info@argenx.com
Main Phone: +31 107038441
Address: Willemstraat 5
City / Town: Breda
Country: NLD
Postal Code: 4811 AH

Issuer Information

Exchange: GREY
CEO: Tim Van Hauwermeiren
Employees: 105
$ 74.29 $ 0. (0.00%)
Last Price 74.29 Change $ 0. Change % 0.00 Tick N/A
Bid N/A Bid Size 0.00 Ask N/A Ask Size 0.00
Open N/A High N/A Low N/A Prev Close 74.29
Last Trade Volume 0 52 Wk Hi 76.04 52 Wk Low 74.29
Market Cap 2.8 bi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 37,991,779.00 EPS (TTM) -2.29 PE Ratio N/A Exchange Greys